The c-MET-JAK1/2-STAT3 signalling axis is regulated by ADAM17 and is a key mediator of resistance to MEK inhibition in KRAS mutant colorectal cancer
- Van Schaeybroeck, S. (Keynote speaker)
Activity: Talk or presentation types › Invited talk
Activity: Talk or presentation types › Invited talk